Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.84
+0.26 (2.25%)
At close: Oct 20, 2026, 4:00 PM EDT
11.90
+0.06 (0.51%)
Pre-market: Oct 21, 2026, 4:12 AM EDT
Intellia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $15 | Hold | Maintains | $15 | +26.69% | Oct 15, 2026 |
| Barclays | Barclays | Sell Initiates $8 | Sell | Initiates | $8 | -32.43% | Oct 6, 2026 |
| Wedbush | Wedbush | Hold Maintains $12 → $13 | Hold | Maintains | $12 → $13 | +9.80% | Sep 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +111.15% | Sep 9, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 4, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $29 | Buy | Maintains | $29 | +144.93% | Aug 14, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $15 | Hold | Reiterates | $15 | +26.69% | Aug 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $49 | Buy | Maintains | $49 | +313.85% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.